172
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data

, , , , , , , & show all
Pages 3349-3357 | Published online: 12 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Ying Lan, Nan Yang, Yirong Wang, Yan Yang, Min Xu & Qin He. (2023) Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2093-2103.
Read now
Guohua Lin, Jiaqi Zheng, Pou Kuan Tang, Yu Zheng, Hao Hu & Carolina Oi Lam Ung. (2022) Effectiveness of Hospital Pharmacist Interventions for COPD Patients: A Systematic Literature Review and Logic Model. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2757-2788.
Read now
Lei Chen, Xianqiu Chen, Canghong Zhi, Xuan Li & Yang Hu. (2022) Levalbuterol vs. albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis. Journal of Medical Economics 25:1, pages 966-973.
Read now
Meng Li, Kun Cheng, Keisun Ku, Junlei Li, Hao Hu & Carolina Oi Lam Ung. (2021) Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1677-1685.
Read now
Lirong Liang, Yunxiao Shang, Wuxiang Xie, Julie Shi, Zhaohui Tong & Mohammad S Jalali. (2020) Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1165-1175.
Read now
Vladimir Jankovic, Slobodan M. Jankovic, Marko Folic & Zorana Djordjevic. (2020) Predictors of antibiotic utilization among intensive care unit patients. Journal of Chemotherapy 32:3, pages 156-159.
Read now

Articles from other publishers (7)

Julie Shi, Lirong Liang & Manqi Hou. (2023) The impacts of China's drug price zero-markup policy on medical expenditures and health outcomes. China Economic Review 79, pages 101949.
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian & Chen Wang. (2023) Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Therapeutic Advances in Respiratory Disease 17, pages 175346662311673.
Crossref
Ariuntuya Tuvdendorj, Otgonjargal Dechinkhorloo, Bayarsaikhan Dorjsuren, Erik Buskens & Talitha Feenstra. (2021) The costs of inappropriate referral pathways in inpatient care for three major noncommunicable diseases in Mongolia: a national registry-based analysis. BMC Health Services Research 21:1.
Crossref
Ahmed Salem, Heng Zhong, Mafalda Ramos, Mark Lamotte & Hao Hu. (2021) Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China. BMJ Open 11:4, pages e043664.
Crossref
Fen Dong, Ke Huang, Xiaoxia Ren, Shiwei Qumu, Hongtao Niu, Yanyan Wang, Yong Li, Minya Lu, Xinshan Lin, Ting Yang, Jianjun Jiao & Chen Wang. (2021) Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016–2017: a retrospective study. BMJ Open 11:2, pages e040560.
Crossref
Hemant Bherwani, Moorthy Nair, Kavya Musugu, Sneha Gautam, Ankit Gupta, Atya Kapley & Rakesh Kumar. (2020) Valuation of air pollution externalities: comparative assessment of economic damage and emission reduction under COVID-19 lockdown. Air Quality, Atmosphere & Health 13:6, pages 683-694.
Crossref
Yan Zeng, Yu Li, Hua Wei, Chan Xiong, Li Liao, Ti-wei Miao, Bing Mao & Juan-juan Fu. (2019) Chinese oral herbal paste for the treatment of stable chronic obstructive pulmonary disease. Medicine 98:28, pages e16444.
Crossref